Researchers Outline Agenda to Elucidate Caregivers’ Experience

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 9
Volume 10
Issue 9

EAST LANSING, Mich-Although much of cancer care now takes place in the outpatient and home setting, the oncology care system has not fully incorporated "family care" for patients at home. While this shift has translated into increased family involvement in day-to-day care, there are few documented, effective strategies to guide family members caring for patients with advanced cancer.

EAST LANSING, Mich—Although much of cancer care now takes place in the outpatient and home setting, the oncology care system has not fully incorporated "family care" for patients at home. While this shift has translated into increased family involvement in day-to-day care, there are few documented, effective strategies to guide family members caring for patients with advanced cancer.

The cover article of the July/August 2001 issue of CA—A Cancer Journal for Clinicians calls for a research agenda to more fully elucidate the cancer caregiver’s experience throughout the illness and treatment trajectory, and identify the means to effecting positive outcomes for people with cancer, their family caregiver, and the health care system.

"Caregivers’ well being must be our concern," say authors Barbara Given, RN, PhD; Charles Given, PhD; and Sharon Kozachik, RN, MSN, of Michigan State University. They suggest four areas for future research: symptom management strategies, patient-caregiver communication, defining patient outcomes, and cost effectiveness. 

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content